Liquidia Corp. (LQDA)
66.74
-1.11
(-1.64%)
USD |
NASDAQ |
Sep 11, 16:00
66.51
-0.23
(-0.34%)
After-Hours: 20:00
Liquidia Market Cap : 5.947B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 5.947B |
| September 10, 2026 | 6.045B |
| September 09, 2026 | 6.159B |
| September 08, 2026 | 6.030B |
| September 04, 2026 | 6.118B |
| September 03, 2026 | 6.115B |
| September 02, 2026 | 6.208B |
| September 01, 2026 | 5.962B |
| August 31, 2026 | 6.074B |
| August 28, 2026 | 6.031B |
| August 27, 2026 | 6.232B |
| August 26, 2026 | 6.358B |
| August 25, 2026 | 6.281B |
| August 24, 2026 | 6.261B |
| August 21, 2026 | 6.114B |
| August 20, 2026 | 6.331B |
| August 19, 2026 | 6.712B |
| August 18, 2026 | 6.623B |
| August 17, 2026 | 6.923B |
| August 14, 2026 | 6.633B |
| August 13, 2026 | 6.424B |
| August 12, 2026 | 7.020B |
| August 11, 2026 | 7.845B |
| August 10, 2026 | 8.111B |
| August 07, 2026 | 8.039B |
| Date | Value |
|---|---|
| August 06, 2026 | 7.897B |
| August 05, 2026 | 7.870B |
| August 04, 2026 | 7.805B |
| August 03, 2026 | 7.405B |
| July 31, 2026 | 7.428B |
| July 30, 2026 | 7.665B |
| July 29, 2026 | 7.667B |
| July 28, 2026 | 7.667B |
| July 27, 2026 | 7.455B |
| July 24, 2026 | 7.614B |
| July 23, 2026 | 7.862B |
| July 22, 2026 | 7.686B |
| July 21, 2026 | 7.143B |
| July 20, 2026 | 6.807B |
| July 17, 2026 | 7.059B |
| July 16, 2026 | 6.647B |
| July 15, 2026 | 6.866B |
| July 14, 2026 | 6.755B |
| July 13, 2026 | 6.288B |
| July 10, 2026 | 6.882B |
| July 09, 2026 | 7.193B |
| July 08, 2026 | 7.018B |
| July 07, 2026 | 7.173B |
| July 06, 2026 | 6.995B |
| July 02, 2026 | 6.970B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Indivior Pharmaceuticals, Inc. | 4.070B |
| Harmony Biosciences Holdings, Inc. | 2.413B |
| Johnson & Johnson | 639.58B |
| United Therapeutics Corp. | 21.22B |
| Amneal Pharmaceuticals, Inc. | 5.432B |
Market Cap Related Metrics
| PE Ratio | 48.92 |
| PS Ratio | 14.39 |
| Price to Book Value | 30.48 |
| Price to Free Cash Flow | 43.06 |
| Price | 66.74 |
| Earnings Yield | 2.04% |
| Operating PE Ratio | 38.49 |
| Normalized PE Ratio | 48.92 |